1st Quarter - Amendment

HELIX, INC. for HELIX, INC.

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 14, 2022 $36,520 Replaced
1st Quarter - Amendment (this page) Aug 3, 2023 $110,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to Genomic research and testing, pandemic preparedness, viral surveillance and sequencing COVID-19 and other respiratory pathogens. Issues relating to the regulation of Lab Developed Tests including the VALID Act, Issues and funding related to the COVID-19 Public Health Emergency, COVID-19 PCR testing, and viral sequencing of COVID-19.

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; White House Office

Medical/Disease Research/Clinical Labs MED

General issues relating to genomic research and testing, COVID-19 testing and research, viral surveillance and sequencing. Regulation of lab developed tests VALID Act discussion drafts.

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES New —

Contacted: Centers For Disease Control & Prevention (CDC); White House Office; HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.